By Connie Calipay

LEGAZPI CITY – The Department of Health-Center for Health Development (DOH-CHD) in Bicol is urging local government units (LGUs) to follow the prioritization guidelines and procedures set by the national government for the coronavirus disease 2019 (Covid-19) vaccination rollout, as it noted a low percentage of vaccinees under the A2 and A3 groups.

Noemi Bron, Health Education and Promotion officer of DOH-CHD Bicol, in an interview on Thursday said they monitor the vaccination coverage of the different provinces through end-of-day reports submitted by the vaccination sites to the Covid-19 Bakuna Center Registry (CBCR) Quick Counts and the Department of Information and Communications Technology (DICT).

“Through this report, the number of vaccinated per priority group is determined,” she said.

Bron said for the A1 group comprising medical front-liners, Bicol region exceeded the percentage target but failed with the A2 and A3 groups or the senior citizens and people with co-morbidities, respectively.

She also noted that it is the national government which determines the number of vaccine doses that Bicol receives.

The local chief executives at the level of the province, city, and municipality implement the vaccination activities as informed by vaccination guidelines and procedures.

Bron also said the DOH-Bicol continuously reminds LGUs and all vaccination sites to adhere to the minimum public health standard during the conduct of vaccination activities.

“Transmission may also be prevented through proper crowd management and identifying the target number of vaccinees to be vaccinated in a day to avoid overcrowding. The public is also enjoined to properly wear face masks and face shields and maintain social distancing and hand sanitation even after receiving the Covid-19 vaccine,” she said.

She said DOH-Bicol appreciates the efforts of LGUs as they continue to encourage individuals to avail of the free Covid-19 vaccines. (PNA)

Advertisement
Please enable JavaScript to view comments powered by Disqus.